Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Clinics ; 67(12): 1463-1468, Dec. 2012. ilus
Artigo em Inglês | LILACS | ID: lil-660476

RESUMO

OBJECTIVE: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats. METHODS: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration. RESULTS: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and gut. CONCLUSION: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.


Assuntos
Animais , Masculino , Ratos , Endotoxemia/metabolismo , Interleucinas/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Nitritos/metabolismo , Estresse Oxidativo , Solução Salina Hipertônica/farmacologia , Síndrome de Resposta Inflamatória Sistêmica/terapia , Modelos Animais de Doenças , Endotoxemia/induzido quimicamente , Hemodinâmica/efeitos dos fármacos , Mediadores da Inflamação/sangue , Doenças Inflamatórias Intestinais/metabolismo , Doenças Inflamatórias Intestinais/patologia , Doenças Inflamatórias Intestinais/prevenção & controle , /metabolismo , /metabolismo , Lipopolissacarídeos/administração & dosagem , Distribuição Aleatória , Ratos Wistar , Análise de Sobrevida , Síndrome de Resposta Inflamatória Sistêmica/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA